Ping Mu 🇺🇦

Associate Professor, Division Chief of Urological Sciences at Yale, study prostate & bladder cancers. Dad of two corgi girls & a human boy. Views are my own.

[Ping Mu 🇺🇦 @PingMu_PhD]

The Mu Lab is using spatial transcriptomics/scRNA-seq-based examining, AI-based prediction, and 3D-cultured organoid-based testing to tackle questions in prostate cancer. ⁦@PCFnews⁩ ⁦@PCF_Science⁩ ⁦⁦@YaleMed⁩ ⁦⁦@Yale_Urology⁩ https://t.co/dN7wqI7RcR

[Ping Mu 🇺🇦 @PingMu_PhD]

My mentor, Dr. Charles Sawyers just delivered a stunning keynote lecture at the 1st Yale Prostate Cancer Symposium, sharing his vision for overcoming lineage plasticity and therapy resistance in prostate cancer. @YaleCancer @Yale_Urology @YaleMed @MSKCancerCenter @Yale

[Ping Mu 🇺🇦 @PingMu_PhD]

Extremely proud of my trainees Yaru Xu and Siyuan Cheng, both got the 2026 AUA Research Scholarship Awards! @Yale_Urology @YaleCancer @Yale @Yaru00473993 @chengsiyuan1004

[Amer. Urol. Assn. @AmerUrological]

👏 Congratulations to our 15 Research Scholar Awardees!

The awardees are rising researchers advancing earlier detection, more personalized therapies and improved outcomes across urologic disease. This year’s awardees represent a diverse range of research areas—from cancer biology and artificial intelligence to pediatric care and infection prevention.

🔗 Click to learn more about the program and the awardees: https://t.co/LYIzitW6Yu

[Ping Mu 🇺🇦 @PingMu_PhD]

@WertLaboratory Most societies like ARVO usually don’t count, since membership is based on dues rather than selectivity. For your student, it may be more effective to focus on other criteria (e.g., publications, citations, reviewer activity, awards, or invited talks).

[Yale Urology @Yale_Urology]

Our own, Isaac Kim, MD, PhD, MBA, recently discussed the predicted decline in death rates over the next 25 years for patients with prostate #cancer. ➡️ https://t.co/yI4ECM7Fvo

@YaleMed | @YaleMedicine | @News12CT | @YaleCancer | @SmilowCancer

[Ping Mu 🇺🇦 @PingMu_PhD]

Excited to share our new work in Cancer Letters!
We identify a HOX code–based framework to define lineage plasticity across cancers and uncover RUNX1T1–HDAC reprogramming as a conserved and targetable mechanism. https://t.co/W7UzlWYJg3

[Ping Mu 🇺🇦 @PingMu_PhD]

@guo_lab LOL thanks

[Ping Mu 🇺🇦 @PingMu_PhD]

New Urologic Sciences Division Bridges Research and Clinical Excellence https://t.co/pIEegsBFyi

[Ping Mu 🇺🇦 @PingMu_PhD]

Martial arts robots dazzle at 2026 Spring Festival Gala https://t.co/N0Dd7noCYF via @YouTube

[Ping Mu 🇺🇦 @PingMu_PhD]

@CKadoch @ScienceMagazine @SiddhantUJain Big big congratulations!🍾🎊🎉

[Ping Mu 🇺🇦 @PingMu_PhD]

@KharasLab @GauravA_UK @bloodgenes @_ruslansoldatov @AbdelWahablab @AlexBickMDPhD Big big congratulations!

[Ping Mu 🇺🇦 @PingMu_PhD]

Happy New Year 🎉 Started 2026 by making a Bernini-style bust of myself with AI modeling and 3D printing. Model design took <10 minutes. Ego inflation: instant. 😂

[Ping Mu 🇺🇦 @PingMu_PhD]

@FaltasLab @WeillCornell @Cornell @HeartBobH @DrScottTagawa @DrDavidNanus @DrChoueiri @ChongPan_HMS @montypal @HsiehLab @PGrivasMDPhD @MarkARubin1 @ElementoLab Big big congratulations my friend, so well deserved! 🎊🍾🎉

[Ping Mu 🇺🇦 @PingMu_PhD]

Dr. Isaac Kim, Chair of Yale Urology, gave a stunning talk on how cytoreductive radical prostatectomy plus systemic therapy can yield deep and durable benefit in ~20% of patients with metastatic prostate cancer, with Dr. Su Deng chairing the session.@Yale_Urology @SuDeng_PhD

[Ping Mu 🇺🇦 @PingMu_PhD]

@YaleCancer @AbdelWahablab @SmilowCancer @MSKCancerCenter @Halene_lab Oh No~~~ missed the super star talk!

[Ping Mu 🇺🇦 @PingMu_PhD]

Thrilled and deeply grateful to Yale leadership for the trust in appointing me as inaugural Chief of the Division of Urologic Sciences in our Department of Urology. Excited to work with our exceptional colleagues to drive innovation and deliver the best medicine for patients.

[Ping Mu 🇺🇦 @PingMu_PhD]

@ODonnellLab_K Congratulations!

[Ping Mu 🇺🇦 @PingMu_PhD]

A true honor to present our AI-driven lineage plasticity study at the Prostate Cancer Foundation Annual Meeting. Great science, great people, and photos that make it look even cooler. 😎📸 @PCFnews @PCF_Science @Yale_Urology @YaleCancer @YaleMed @Yale

[Ping Mu 🇺🇦 @PingMu_PhD]

@TylerSbrt @mleapman @Yale_Urology @YaleCancer @YaleMed @ClevelandClinic He won 🥇

[Ping Mu 🇺🇦 @PingMu_PhD]

🌟 Star vs. Star! Our own Dr. Michael Leapman takes on the legendary Dr. Kaouk in the ultimate showdown: single-port vs. multi-port robotic assisted radical prostatectomy! ⚔️🤖 @Yale_Urology @YaleCancer @YaleMed @ClevelandClinic @mleapman

[Ping Mu 🇺🇦 @PingMu_PhD]

It was a great pleasure to visit Pfizer to present and discuss our recent findings on prostate cancer therapy resistance, and to engage with many colleagues, both old and new. I look forward to future scientific collaborations. @Yale_Urology @YaleCancer @YaleMed @Yale